Doxepin 6 mg tablet is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Doxepin
- Brand
- Sold under the generic name
- Strength
- 6 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 500 tablets, 100 tablets and 32 more
- Manufacturers
- Viona PharmaceuticalsIndiaZydus LifesciencesIndiaNovadoz PharmaceuticalsIndiaStrides PharmaIndiaAjanta PharmaIndiaAurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaArchis PharmaBryant Ranch PrepackGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2010
- Identifiers
- RxCUI 966787, 966793DailyMed set ID 77782f36-d120-4c3d-bebd-c8b0f4749d98, 1461ede6-24f0-42a1-b801-0cf4ef404985, 207bb11e-6029-4506-92d2-2d8a776b9408 +16NDC 72603-920, 70771-1529, 72162-2475 +16Application ANDA216041, ANDA202761, ANDA202510 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 27241-281-30 | Ajanta PharmaIndia | 1 July 2024 |
| 30 tablet in 1 bottle | 59651-845-30 | Aurobindo PharmaIndia | 12 July 2025 |
| 500 tablet in 1 bottle | 72205-053-05 | Novadoz PharmaceuticalsIndia | 5 April 2023 |
| 30 tablet in 1 bottle | 72205-053-30 | Novadoz PharmaceuticalsIndia | 5 April 2023 |
| 100 tablet in 1 bottle | 72205-053-91 | Novadoz PharmaceuticalsIndia | 5 April 2023 |
| 30 tablet in 1 bottle, plastic | 64380-204-01 | Strides PharmaIndia | 12 September 2022 |
| 100 tablet in 1 bottle, plastic | 64380-204-02 | Strides PharmaIndia | 12 September 2022 |
| 500 tablet in 1 bottle, plastic | 64380-204-03 | Strides PharmaIndia | 12 September 2022 |
| 30 tablet in 1 bottle | 51672-4247-2 | Sun Pharmaceutical IndustriesIndia | 7 August 2025 |
| 100 tablet in 1 bottle | 72578-182-01 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 500 tablet in 1 bottle | 72578-182-05 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 30 tablet in 1 bottle | 72578-182-06 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 1000 tablet in 1 bottle | 72578-182-10 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 90 tablet in 1 bottle | 72578-182-16 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 72578-182-77 | Viona PharmaceuticalsIndia | 30 June 2024 |
| 1000 tablet in 1 bottle | 70771-1529-0 | Zydus LifesciencesIndia | 30 June 2024 |
| 100 tablet in 1 bottle | 70771-1529-1 | Zydus LifesciencesIndia | 30 June 2024 |
| 30 tablet in 1 bottle | 70771-1529-3 | Zydus LifesciencesIndia | 30 June 2024 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70771-1529-4 | Zydus LifesciencesIndia | 30 June 2024 |
| 500 tablet in 1 bottle | 70771-1529-5 | Zydus LifesciencesIndia | 30 June 2024 |
| 90 tablet in 1 bottle | 70771-1529-9 | Zydus LifesciencesIndia | 30 June 2024 |
| 30 tablet, film coated in 1 bottle | 0228-3316-03 | Actavis Pharma | 2 January 2020 |
| 30 tablet, film coated in 1 bottle | 72819-162-03 | Archis Pharma | 21 February 2022 |
| 100 tablet, film coated in 1 bottle | 72819-162-10 | Archis Pharma | 21 February 2022 |
| 500 tablet, film coated in 1 bottle | 72819-162-11 | Archis Pharma | 21 February 2022 |
| 30 tablet in 1 bottle | 44183-106-30 | Cypress, Hawthorn, Macoven | 1 August 2010 |
| 30 tablet, film coated in 1 bottle | 72603-223-01 | North Star Rx | 1 April 2024 |
| 100 tablet in 1 bottle | 71335-3177-1 | Bryant Ranch Prepack | 24 September 2026 |
| 30 tablet in 1 bottle | 72162-2475-3 | Bryant Ranch Prepack | 1 May 2025 |
| 30 tablet in 1 bottle | 51407-728-30 | Golden State Medical Supply | 20 April 2026 |
| 30 tablet in 1 bottle | 51407-812-30 | Golden State Medical Supply | 31 May 2023 |
| 30 pouch in 1 box / 1 tablet in 1 pouch | 70518-4297-0 | Remedyrepack | 27 February 2025 |
| 30 pouch in 1 box / 1 tablet in 1 pouch | 70518-4327-0 | Remedyrepack | 13 April 2025 |
| 30 tablet, film coated in 1 bottle | 10135-764-30 | Marlex Pharmaceuticals | 1 October 2023 |
| 30 tablet in 1 bottle | 72603-920-01 | NorthStar Rx | 1 August 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 September 1969 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Doxepin 6 mg tablet.
Other strengths and forms of Doxepin
Clinical summary
Doxepin is a tricyclic antidepressant indicated for the short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis or lichen simplex chronicus. MedsAcross supplies Doxepin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxepinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PRUDOXIN prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Doxepin 6 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.